TrueBlue price target lowered to $12 from $13 at BMO Capital

BMO Capital lowered the firm’s price target on TrueBlue to $12 from $13 but keeps an Outperform rating on the shares. The company’s Q2 marked a a disappointing quarter with both revenues and profits below consensus, and the decline was broad-based with softer volumes across most verticals and geographies, though TrueBlue can still outperform the group when the sector rebounds, the analyst tells investors in a research note.